Paragonix Technologies today announced the world’s first successful human use of its PancreasPak Organ Preservation System. The technology was used at Tampa General Hospital Transplant Institute in a recent pancreas transplant, advancing efforts to enhance organ preservation for better transplant outcomes. Dr. Matthew Hunter Witt, a transplant surgeon at Tampa General Hospital, led the case. […]
Paragonix Technologies
FDA clears Paragonix KidneyVault portable renal perfusion system
Paragonix Technologies this week announced it received FDA 510(k) clearance for its KidneyVault donor kidney preservation system. KidneyVault is Paragonix’s first perfusion device. The company designed it to streamline digital monitoring capabilities with portable hypothermic perfusion technology to help protect donor kidneys during transport. The system also expands the kidney donor pool. Paragonix said it […]
Paragonix announces first pediatric use of BAROguard lung preservation system
Paragonix today announced the first pediatric use of its BAROguard Donor Lung Preservation System in a lung transplant case. The donor lungs were successfully implanted by Dr. Mindaugas Rackauskas and Dr. Mark Bleiweis at UF Shands Children’s Hospital in Gainesville, Florida. The system won FDA clearance in August 2023 and commercially launched in April. “UF […]
Paragonix expands liver transplant registry
Paragonix today announced a significant expansion of its GUARDIAN-Liver clinical registry with the appointment of a new principal investigator. The Waltham, Massachusetts-based organ transplant technology developer — which Getinge acquired for $477 million last month — now has more than 500 enrollments in its clinical registry for its liver preservation and transport technologies. With this […]
Getinge completes $477M Paragonix acquisition
Getinge today announced that it completed its previously announced acquisition of Paragonix Technologies for up to $477 million. Last month, the companies inked a definitive agreement under which Getinge would acquire the Massachusetts-based organ transplant technology developer. Getinge expects the deal to enhance its global healthcare portfolio while addressing needs in solid organ transplantation. Additionally, […]
Getinge to acquire organ preservation tech company Paragonix for $477M
Paragonix and Getinge announced a definitive agreement under which Getinge acquires the organ transplant technology developer. The total price of the acquisition, including upfront and earnout payments, could reach approximately $477 million. Getinge expects the deal to enhance its global healthcare portfolio while addressing needs in solid organ transplantation. The Sweden-based company can expand access to […]
Paragonix reports first pediatric use of liver preservation system
Paragonix Technologies today announced the first liver transplant case preserving a pediatric donor liver with the Liverguard preservation system. Dr. Deepak Vikraman successfully transplanted the donor liver at Duke University Hospital in Durham, North Carolina. “This case exemplifies the importance of employing the latest innovations in transplant preservation within pediatric care,” said Vikraman. “New technologies […]
Paragonix launches pancreas preservation system
Paragonix Technologies announced today that it launched the FDA-cleared PancreasPak organ preservation system. PancreasPak becomes the first FDA-cleared device designed to protect and monitor donor pancreases during transportation to hit the market. Pre-orders begin today, June 27, with full availability earmarked for Sept. 1, 2024. Waltham, Massachusetts-based Paragonix expects PancreasPak to “transform the pancreatic transplant […]
Paragonix has positive long-term data on heart preservation
Paragonix Technologies today announced positive long-term registry results demonstrating improvements after heart transplantation. Results from the GUARDIAN-Heart registry demonstrated statistically significant improvements in 2-year survival following heart transplantation. The analysis consisted of a total of 1,261 U.S. adult patients matched using statistical propensity matching. This created two cohorts of equal baseline characteristics to compare the […]
Paragonix begins full U.S. launch of donor lung preservation system
Paragonix Technologies announced today that it began the full commercial launch of its Baroguard donor lung preservation system. Baroguard, a first-of-its-kind system, offers an alternative to the current practices. These practices see donor lungs preserved and transported from an inflated state between donor and recipient. Those current organ recovery techniques fail to reliably maintain and […]
Paragonix announces first human use of donor lung preservation system
Paragonix Technologies announced today that it successfully completed the first-in-human case using its new donor lung preservation technology. Waltham, Massachusetts-based Paragonix received FDA clearance for the BAROguard donor lung preservation system in August. It offers an alternative to the current practices. These practices see donor lungs preserved and transported from an inflated state between donor […]